RA
DBD

Royce & Associates’s Diebold Nixdorf Incorporated DBD Stock Holding History

Royce & Associates’s Portfolio DBD Stock Details DBD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-345,400
Closed -$4.13M – 1234
2018
Q2 		$4.13M Sell
345,400
-590,492
-63% -$7.9M 0.03% 645
2018
Q1 		$14.4M Sell
935,892
-172,257
-16% -$2.88M 0.1% 281
2017
Q4 		$18.1M Sell
1,108,149
-176,077
-14% -$3.4M 0.12% 238
2017
Q3 		$29.3M Sell
1,284,226
-409,024
-24% -$8.71M 0.19% 135
2017
Q2 		$47.4M Sell
1,693,250
-142,800
-8% -$3.95M 0.31% 73
2017
Q1 		$56.4M Sell
1,836,050
-62,800
-3% -$1.77M 0.37% 60
2016
Q4 		$47.8M Sell
1,898,850
-71,800
-4% -$1.69M 0.31% 80
2016
Q3 		$48.9M Sell
1,970,650
-150,000
-7% -$3.98M 0.32% 81
2016
Q2 		$52.7M Sell
2,120,650
-416,800
-16% -$10.7M 0.35% 66
2016
Q1 		$73.4M Sell
2,537,450
-67,676
-3% -$1.77M 0.46% 39
2015
Q4 		$78.4M Buy
2,605,126
+493,600
+23% +$16.8M 0.47% 38
2015
Q3 		$62.9M Buy
2,111,526
+7,264
+0.3% +$236K 0.33% 71
2015
Q2 		$73.6M Buy
2,104,262
+85,162
+4% +$3M 0.31% 80
2015
Q1 		$71.6M Sell
2,019,100
-187,700
-9% -$6.32M 0.27% 92
2014
Q4 		$76.4M Sell
2,206,800
-77,150
-3% -$2.72M 0.27% 97
2014
Q3 		$80.7M Buy
2,283,950
+34,600
+2% +$1.31M 0.27% 90
2014
Q2 		$90.4M Buy
2,249,350
+217,450
+11% +$8.34M 0.27% 88
2014
Q1 		$81.1M Buy
2,031,900
+100,000
+5% +$3.6M 0.24% 104
2013
Q4 		$63.8M Sell
1,931,900
-19,300
-1% -$602K 0.18% 149
2013
Q3 		$57.3M Buy
1,951,200
+497,200
+34% +$15.6M 0.17% 153
2013
Q2 		$49M Buy
+1,454,000
New +$45M 0.15% 180

Other funds holding DBD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AIM
Atlantic Investment Management New York $172M AUM 39.5% 1-Year Est. Return
GI
GAMCO Investors Greenwich, Connecticut $10.2B AUM 30.27% 1-Year Est. Return
SAM
Southernsun Asset Management Memphis, Tennessee $690M AUM 30.68% 1-Year Est. Return
SI
Sapience Investments Newport Beach, California $772K AUM 24.07% 1-Year Est. Return
KGI
Kopernik Global Investors Tampa, Florida $1.43B AUM 63.57% 1-Year Est. Return
PGCM
Prescott Group Capital Management Tulsa, Oklahoma $1B AUM 51.95% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return

Royce & Associates's DBD Position: Q3 2018 in Review

Royce & Associates sold out of Diebold Nixdorf Incorporated (DBD) in Q3 2018, closing a stake of 345,400 shares — an estimated $4.13M sold.

Royce & Associates first reported a position in DBD in Q2 2013 and held it in 21 quarters. The position peaked at $90.4M in Q2 2014. 201 funds tracked by Wall St. Rank hold DBD as of Q3 2018.

  • Royce & Associates reported no remaining Diebold Nixdorf Incorporated position as of Q3 2018 after selling out during the quarter.
  • Royce & Associates sold 345,400 Diebold Nixdorf Incorporated shares in Q3 2018, an estimated $4.13M.
  • Royce & Associates first reported a position in Diebold Nixdorf Incorporated in Q2 2013 and held it in 21 quarters.
  • Royce & Associates's Diebold Nixdorf Incorporated position peaked at $90.4M in Q2 2014.
  • 201 funds tracked by Wall St. Rank held Diebold Nixdorf Incorporated as of Q3 2018.

Based on Royce & Associates's 13F filing for Q3 2018, filed 13 Nov 2018.